+Compare
FEMY
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$2.20
Change
+$0.10 (+4.76%)
Capitalization
25.99M

FEMY Price Prediction, Femasys AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

Momentum Indicator for FEMY turns positive, indicating new upward trend

FEMY saw its Momentum Indicator move above the 0 level on August 05, 2022. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator turned positive. In 24 of the 28 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

FEMY moved above its 50-day moving average on August 02, 2022 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FEMY advanced for three days, in of 43 cases, the price rose further within the following month. The odds of a continued upward trend are .

FEMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for FEMY moved out of overbought territory on June 30, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator moved out of overbought territory. In of the 1 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for FEMY turned negative on July 14, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FEMY entered a downward trend on August 05, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.106) is normal, around the industry mean (17.059). P/E Ratio (0.000) is within average values for comparable stocks, (93.546). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.752). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (22.173) is also within normal values, averaging (92.278).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FEMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

FEMY is expected to report earnings to rise 4.17% to -25 cents per share on August 10

Femasys FEMY Stock Earnings Reports
Q2'22
Est.
$-0.25
Q1'22
Missed
by $0.03
Q4'21
Beat
by $0.02
Q3'21
Missed
by $0.04
Q2'21
Missed
by $0.27
The last earnings report on May 11 showed earnings per share of -23 cents, missing the estimate of -20 cents. With 27.90K shares outstanding, the current market capitalization sits at 25.99M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.23B. The market cap for tickers in the group ranges from 775 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 6%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -16%. APDN experienced the highest price growth at 722%, while HSDT experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 55%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was 55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 73
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 83
Seasonality Score: 2 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
3950 Johns Creek Court
Phone
+1 770 500-3910
Employees
29
Web
https://www.femasys.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NERV4.950.25
+5.32%
Minerva Neurosciences
CDZI4.230.16
+3.93%
CADIZ
GET1.720.03
+1.78%
Getnet Adquirencia e Servicos para Meios de Pagamento SA
RUSHB54.980.66
+1.22%
Rush Enterprises
SSNC60.67-0.16
-0.26%
SS&C Technologies Holdings

FEMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, FEMY has been loosely correlated with SERA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FEMY jumps, then SERA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
+7.84%
SERA - FEMY
35%
Loosely correlated
-6.17%
SENS - FEMY
29%
Poorly correlated
+3.94%
VIVE - FEMY
28%
Poorly correlated
-0.25%
HYPR - FEMY
27%
Poorly correlated
+9.25%
ABMD - FEMY
26%
Poorly correlated
-0.25%
More